Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

Astellas Pharma Set to Unveil State-of-the-Art Life Sciences Facility in Massachusetts, USA

Introduction:

Astellas Pharma opens a new state-of-the-art life sciences facility to expand its R&D footprint in order to accelerate innovation and deliver VALUE to patients.

Features: 

The new facility is set to utilise two floors encompassing approximately covering 62,000 square feet.

This facility will accommodate both laboratory and office spaces to house the discovery accelerator.

The facility will become the operational hub for several diverse functions including medical & development, business development, and research.

This investment stands as a testament to enduring growth in the Greater Boston vicinity, as well as its endeavour to foster novel centres of innovation and synergy.

The forthcoming establishment will foster a harmonious environment, facilitating seamless collaboration to harness the wide-ranging expertise both within the organisation and beyond its confines.

The upcoming facility is anticipated to open in 2024.

Specifications:

Name Astellas Pharma
Type New Construction
Year 2024

magazine-slider-imageBIOVIA from Molecule to MedicineMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinRehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024